Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating coronary heart disease and preparation process thereof

A technology for coronary heart disease and medicine, applied in the field of medicine for the treatment of coronary heart disease, can solve the problems of low content of active ingredients, slow absorption, backward production process, etc.

Inactive Publication Date: 2011-04-27
TIANJIN TASLY MORDEN TCM RESOURCES
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are ordinary compound Danshen tablets and capsules on the market, but the production technology of ordinary tablets and capsules is backward, the content of active ingredients is low, and there is no quality control index. It needs to be taken orally and absorbed through the gastrointestinal tract, and absorbed after the first-pass effect in the liver. Into the blood, low bioavailability, slow absorption. It is not suitable for the first aid needs of patients with angina pectoris

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for treating coronary heart disease and preparation process thereof
  • Medicament for treating coronary heart disease and preparation process thereof
  • Medicament for treating coronary heart disease and preparation process thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0065] Embodiment 1 The preparation of the drug drop pill for the treatment of coronary heart disease, each component is made up of the weight percent of active ingredient of medicine in terms of crude drug: Salvia miltiorrhiza 82.87%, Radix Notoginseng 16.21%, Borneol 0.92%;

[0066] Step 1: add 3 times the amount of 95% ethanol to Danshen and Panax notoginseng, extract under reflux for 2 hours, and filter; add 2 times the amount of 95% ethanol to the dregs, extract under reflux for 1 hour, filter, concentrate the extract under reduced pressure, and dry to obtain Salvia miltiorrhiza Seven 95% alcohol extract;

[0067] Step 2, add 5 times the amount of 40% ethanol to the residues of Danshen and Panax notoginseng obtained after the alcohol extraction in step 1 for reflux extraction for 1.5 hours, and filter; add 4 times the amount of 50% ethanol to the remaining medicinal residues and add 4 times the amount of reflux extraction for 1 hour, filter, and extract The liquid is conc...

Embodiment 2

[0070] Embodiment 2 The preparation of the medicine dripping pill for the treatment of coronary heart disease, each component is made up of the weight percentage of active ingredient of medicine in terms of crude drug: Salvia miltiorrhiza 19.8%, Radix Notoginseng 78.2%, Borneol 2%;

[0071] Step 1: add twice the amount of 85% ethanol to Danshen and Panax notoginseng, reflux extraction once, for 1 hour each time, filter, concentrate the extract under reduced pressure, and dry to obtain 85% alcohol extract of Danshen notoginseng;

[0072] Step 2, add 5 times the amount of 40% ethanol to the residues of Danshen and Panax notoginseng obtained after the alcohol extraction in step 1 for reflux extraction for 1.5 hours, and filter; add 4 times the amount of 50% ethanol to the remaining medicinal residues and add 4 times the amount of reflux extraction for 1 hour, filter, and extract The liquid is concentrated under reduced pressure and dried. Add water to dissolve to 48-52% sugar cont...

Embodiment 3

[0075] Example 3 Preparation of medicine for treating coronary heart disease, each component is composed of 97% of salvia miltiorrhiza, 2% of notoginseng, and 1% of borneol in terms of crude drug.

[0076] Step 1: add 5 times the amount of 95% ethanol to Danshen and Panax notoginseng, reflux extraction for 3 times, each time for 3 hours, filter, concentrate the extract under reduced pressure, and dry to obtain 95% alcohol extract of Danshen notoginseng;

[0077] Step 2, add 5 times the amount of 40% ethanol to the residues of Danshen and Panax notoginseng obtained after the alcohol extraction in step 1 for reflux extraction for 1.5 hours, and filter; add 4 times the amount of 50% ethanol to the remaining medicinal residues and add 4 times the amount of reflux extraction for 1 hour, filter, and extract The liquid is concentrated under reduced pressure and dried. Add water to dissolve to 48-52% sugar content, add ethanol to make the alcohol content reach 70%, let it stand for mor...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicament for treating coronary heart disease and a preparation process thereof. The preparation process comprises the steps of ethanol extraction of root of red rooted salvia and root of pseudo-ginseng, water extraction of the decoction dregs of the root of red rooted salvia and the root of pseudo-ginseng, and the like. The preparation process has the advantages that: the process can realize industrialization, and the quality is stable and controllable. Related experiments show that: the medicament has high curative effect compared with the prior art; the medicament has high purity, good absorption, stable quality and novel application; and meanwhile, the preparation process is simple and convenient for operation, has low cost, and is suitable for industrialized production.

Description

technical field [0001] The invention relates to a medicine for treating coronary heart disease, which belongs to the field of traditional Chinese medicine. Background technique [0002] With the improvement of living standards, the aging of the world's population and the rejuvenation of the disease population, cardiovascular and cerebrovascular patients are increasing year by year, and have become the second largest disease that endangers human health. Angina pectoris is a clinical syndrome caused by temporary myocardial ischemia and hypoxia, with episodic chest pain or chest discomfort as the main manifestation. Coronary heart disease angina pectoris refers to angina pectoris caused by myocardial ischemia and hypoxia due to coronary artery sclerosis or spasm, accounting for about 90% of angina pectoris patients. [0003] The current methods of treating angina pectoris mainly focus on dilating blood vessels, reducing blood viscosity, anti-platelet aggregation, and anti-coag...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/537A61K9/20A61P9/10A61K31/045
Inventor 刘顺航徐波戚可人刘岩陈红丛德刚赵国辉
Owner TIANJIN TASLY MORDEN TCM RESOURCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com